{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:05:32Z","timestamp":1789423532458,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejpn.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T21:13:29Z","timestamp":1612991609000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Melatonin for neuroprotection in neonatal encephalopathy: A systematic review & meta-analysis of clinical trials"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6202-8725","authenticated-orcid":false,"given":"Javed","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Kareem","family":"Pullattayil S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1786-0002","authenticated-orcid":false,"given":"Kiran","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejpn.2021.02.003_bib1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpn.2008.05.001","article-title":"A\u00a0review of developmental outcomes of term infants with post-asphyxia neonatal encephalopathy","volume":"13","author":"Pin","year":"2009","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.003_bib2","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy","volume":"2013","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"15","key":"10.1016\/j.ejpn.2021.02.003_bib3","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMcps050929","article-title":"Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy","volume":"353","author":"Shankaran","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ejpn.2021.02.003_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa1315788","article-title":"Effects of hypothermia for perinatal asphyxia on childhood outcomes","volume":"371","author":"Azzopardi","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.003_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/archdischild-2018-316509","article-title":"School-age outcomes of children without cerebral palsy cooled for neonatal hypoxic\u2013ischaemic encephalopathy in 2008\u20132010","volume":"105","author":"Lee-Kelland","year":"2020","journal-title":"Arch Dis Child - Fetal Neonatal"},{"issue":"12","key":"10.1016\/j.ejpn.2021.02.003_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208302","article-title":"Maternal chorioamnionitis and neurodevelopmental outcomes in preterm and very preterm neonates: a meta-analysis","volume":"13","author":"Xiao","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.ejpn.2021.02.003_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnsyn.2019.00034","article-title":"An assessment of melatonin\u2019s therapeutic value in the hypoxic-ischemic encephalopathy of the newborn","volume":"11","author":"Cardinali","year":"2019","journal-title":"Front. Synaptic Neurosci."},{"issue":"4","key":"10.1016\/j.ejpn.2021.02.003_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1515\/jpm-2018-0360","article-title":"Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis","volume":"47","author":"Razak","year":"2019","journal-title":"J.\u00a0Perinat. Med."},{"issue":"9","key":"10.1016\/j.ejpn.2021.02.003_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/jp.2013.65","article-title":"Magnesium for newborns with hypoxic-ischemic encephalopathy: a systematic review and meta-analysis","volume":"33","author":"Tagin","year":"2013","journal-title":"J.\u00a0Perinatol."},{"key":"10.1016\/j.ejpn.2021.02.003_bib10","first-page":"CD006817","article-title":"Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy","volume":"7","author":"Chaudhari","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.ejpn.2021.02.003_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(15)00347-6","article-title":"Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial","volume":"15","author":"Azzopardi","year":"2016","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2021.02.003_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41419-019-1556-7","article-title":"Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care","volume":"10","author":"Tarocco","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejpn.2021.02.003_bib13","first-page":"9626715","article-title":"Melatonin in hypoxic-ischemic brain injury in term and preterm babies","volume":"2019","author":"Paprocka","year":"2019","journal-title":"Internet J. Endocrinol."},{"issue":"12","key":"10.1016\/j.ejpn.2021.02.003_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules22122115","article-title":"Melatonin pharmacokinetics following oral administration in preterm neonates","volume":"22","author":"Carloni","year":"2017","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ejpn.2021.02.003_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jpi.12565","article-title":"Melatonin pharmacokinetics and dose extrapolation after enteral infusion in neonates subjected to hypothermia","volume":"66","author":"Balduini","year":"2019","journal-title":"J.\u00a0Pineal Res."},{"issue":"2","key":"10.1016\/j.ejpn.2021.02.003_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-079X.2008.00649.x","article-title":"Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin","volume":"46","author":"Gitto","year":"2009","journal-title":"J.\u00a0Pineal Res."},{"issue":"4","key":"10.1016\/j.ejpn.2021.02.003_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jpeds.2011.12.052","article-title":"Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?","volume":"160","author":"Robertson","year":"2012","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ejpn.2021.02.003_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnsyn.2019.00034","article-title":"An assessment of melatonin\u2019s therapeutic value in the hypoxic-ischemic encephalopathy of the newborn","volume":"11","author":"Cardinali","year":"2019","journal-title":"Front. Synaptic Neurosci."},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.003_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/brain\/aws285","article-title":"Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model","volume":"136","author":"Robertson","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2021.02.003_bib20","series-title":"No Title","year":"2014"},{"issue":"oct18 2","key":"10.1016\/j.ejpn.2021.02.003_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ejpn.2021.02.003_bib22","series-title":"GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations","author":"Sch\u00fcnemann","year":"2010"},{"issue":"4","key":"10.1016\/j.ejpn.2021.02.003_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3233\/NPM-181830","article-title":"A\u00a0randomized controlled trial on the use of magnesium sulfate and melatonin in neonatal hypoxic ischemic encephalopathy","volume":"12","author":"El Farargy","year":"2020","journal-title":"J.\u00a0Neonatal Perinat. Med."},{"issue":"4","key":"10.1016\/j.ejpn.2021.02.003_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1034\/j.1600-079X.2001.310409.x","article-title":"Increased levels of malondialdehyde and nitrite\/nitrate in the blood of asphyxiated newborns: reduction by melatonin","volume":"31","author":"Fulia","year":"2001","journal-title":"J.\u00a0Pineal Res."},{"issue":"8","key":"10.1016\/j.ejpn.2021.02.003_bib25","first-page":"1233","article-title":"Role of melatonin in management of hypoxic ischaemic encephalopathy in newborns: a randomized control trial","volume":"68","author":"Ahmad","year":"2018","journal-title":"J.\u00a0Pakistan Med. Assoc."},{"issue":"3","key":"10.1016\/j.ejpn.2021.02.003_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jp.2014.186","article-title":"Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study","volume":"35","author":"Aly","year":"2015","journal-title":"J.\u00a0Perinatol."},{"key":"10.1016\/j.ejpn.2021.02.003_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/PCC.0000000000002346","article-title":"Hypothermia plus melatonin in asphyctic newborns: a randomized-controlled pilot study","author":"Jerez-Calero","year":"2020","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.ejpn.2021.02.003_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ctim.2018.11.003","article-title":"Adverse events associated with oral administration of melatonin: a critical systematic review of clinical evidence","volume":"42","author":"Foley","year":"2019","journal-title":"Compl. Ther. Med."},{"issue":"8","key":"10.1016\/j.ejpn.2021.02.003_bib29","doi-asserted-by":"crossref","first-page":"901\u2014909","DOI":"10.1007\/s00228-015-1873-4","article-title":"Clinical pharmacokinetics of melatonin: a systematic review","volume":"71","author":"Harps\u00f8e","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpn.2021.02.003_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.nbd.2018.10.004","article-title":"Melatonin as an adjunct to therapeutic hypothermia in a piglet model of neonatal encephalopathy: a translational study","volume":"121","author":"Robertson","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejpn.2021.02.003_bib31","article-title":"Melatonin and\/or erythropoietin combined with hypothermia in a piglet model of perinatal asphyxia","author":"Pang","year":"2020","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.003_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/jcbfm.2013.174","article-title":"Partial neural protection with prophylactic low-dose melatonin after asphyxia in preterm fetal sheep","volume":"34","author":"Drury","year":"2014","journal-title":"J\u00a0Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.ejpn.2021.02.003_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1203\/01.pdr.0000252546.20451.1a","article-title":"Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion","volume":"61","author":"Welin","year":"2007","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ejpn.2021.02.003_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fncel.2017.00296","article-title":"The beneficial effects of melatonin administration following hypoxia-ischemia in preterm fetal sheep","volume":"11","author":"Yawno","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.003_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12264-016-0080-3","article-title":"Low-dose ethanol preconditioning protects against oxygen-glucose deprivation\/reoxygenation-induced neuronal injury by activating large conductance, Ca(2+)-Activated K(+) Channels in\u00a0Vitro","volume":"33","author":"Su","year":"2017","journal-title":"Neurosci Bull"},{"issue":"2","key":"10.1016\/j.ejpn.2021.02.003_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainresrev.2010.09.003","article-title":"Ethanol-enhanced GABA release: a focus on G protein-coupled receptors","volume":"65","author":"Kelm","year":"2011","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejpn.2021.02.003_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.curtheres.2014.09.002","article-title":"Ethanol pharmacokinetics in neonates and infants","volume":"76","author":"Marek","year":"2014","journal-title":"Curr. Ther. Res. Clin. Exp."},{"issue":"6","key":"10.1016\/j.ejpn.2021.02.003_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028243","article-title":"Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction","volume":"9","author":"Palmer","year":"2019","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.ejpn.2021.02.003_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004141","article-title":"Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction\u2014a phase I pilot clinical trial: study protocol","volume":"3","author":"Alers","year":"2013","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ejpn.2021.02.003_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003788","article-title":"Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol","volume":"3","author":"Hobson","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejpn.2021.02.003_bib41","series-title":"Therapeutic Effects of Maternal Melatonin Administration on Brain Injury and White Matter Disease (PREMELIP)","year":"2020"},{"issue":"4","key":"10.1016\/j.ejpn.2021.02.003_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2018-315478","article-title":"Proton magnetic resonance spectroscopy lactate\/N-acetylaspartate within 2 weeks of birth accurately predicts 2-year motor, cognitive and language outcomes in neonatal encephalopathy after therapeutic hypothermia","volume":"104","author":"Mitra","year":"2018","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"1","key":"10.1016\/j.ejpn.2021.02.003_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(18)30325-9","article-title":"Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multicentre cohort study","volume":"18","author":"Lally","year":"2019","journal-title":"Lancet Neurol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379821000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379821000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:37:32Z","timestamp":1761071852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379821000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":43,"alternative-id":["S1090379821000155"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2021.02.003","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin for neuroprotection in neonatal encephalopathy: A systematic review & meta-analysis of clinical trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}